跳至主要内容
临床试验/NCT01856231
NCT01856231已完成不适用

Lifestyle Physical Activity for People With COPD

University of Michigan2 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2011年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
2
主要终点
Change in physical activity measured by accelerometry

研究概览

简要总结

The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training. The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD. The intervention includes a combination of (a) structured laboratory-based exercises with a behavioral intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home. The subjects will be followed for a total of 18 weeks.

详细描述

People with chronic obstructive pulmonary disease (COPD) experience a gradual decline in physical activity (PA). Exercise training in a structured pulmonary rehabilitation program can generate substantial gains in functional capacity, but increases in functional capacity do not necessarily lead to improvements in daily PA. The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD. The intervention includes a combination of (a) structured laboratory-based exercises with a self-efficacy enhancing intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home. The intervention gradually transitions subjects from the structured laboratory-based exercises that focus on walking and circuit training to fully integrated lifestyle physical activities that integrate structured home-based exercises and lifestyle physical activities into daily life. The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training and subjects will be followed for a total of 18 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 55 years or older
  • Moderate to severe COPD (FEV1 < 80% and > 30% predicted; FEV1/FVC <70%) as the primary health problem
  • Sedentary (less than 30 minutes of moderate activity 3 days/week)

排除标准

  • No acute exacerbations or major illnesses requiring hospitalization in the last 8 weeks.
  • No history of other major lung diseases as primary pulmonary problem, history of a recent heart attack or recent onset of chest pains with activity or increasing episodes of chest pain (unstable angina).
  • No other health problems or mobility problems that limit physical activity.
  • No child bearing potential

研究组 & 干预措施

8 week group

Experimental

Lifestyle physical activity self-efficacy

干预措施: Lifestyle physical activity - self-efficacy (Behavioral)

结局指标

主要结局

Change in physical activity measured by accelerometry

时间窗: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18

Subjects wear two activity monitors for seven consecutive days (Actipal and Actigraph). The study will compare the subject's activity level at the three time points listed.

次要结局

  • Change in dyspnea and fatigue (Pulmonary Functional Status and Dyspnea Questionnaire-Modified)(During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18)
  • Change in physical activity measured by CHAMPS questionnaire(During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18)
  • Change in 6 minute walk test(During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18)
  • Change in lower extremity function (Short Physical Performance Battery)(During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Janet L. Larson

Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验

Lifestyle Physical Activity for People With COPD | 临床试验